Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyang Ren

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Gastroenterology Report|March 22, 2021
Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocolLiang Kang, Ziwei Zeng, Shuangling Luo, et al.
Annals of Translational Medicine|May 16, 2022
Structured training curriculums for transanal total mesorectal excision in China: refinement is neededXimo Xu, Zhenghao Cai, Hong Zhang, et al.
International Journal of Colorectal Disease|January 4, 2021
Multicenter investigation of bowel evacuation function after transanal total mesorectal excision for mid-low rectal cancerZhanlong Shen, Gang Yu, Mingyang Ren, et al.
Annals of Surgery|July 11, 2022
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled TrialHuashan Liu, Ziwei Zeng, Hong Zhang, et al.
JAMA|January 23, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical TrialZiwei Zeng, Shuangling Luo, Hong Zhang, et al.
Science Bulletin|December 22, 2022
Short-term and oncological outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer in China: a national database study of 5055 patientsXu Guan, Xiyue Hu, Zheng Jiang, et al.
The Lancet. Gastroenterology & Hepatology|March 26, 2026
Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trialJurriaan B Tuynman, Hongwei Yao, Laura R Moolenaar, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Gastroenterology Report|March 22, 2021
Transanal vs laparoscopic total mesorectal excision for rectal cancer: a multicenter randomized phase III clinical trial (TaLaR trial) protocolLiang Kang, Ziwei Zeng, Shuangling Luo, et al.
Annals of Translational Medicine|May 16, 2022
Structured training curriculums for transanal total mesorectal excision in China: refinement is neededXimo Xu, Zhenghao Cai, Hong Zhang, et al.
International Journal of Colorectal Disease|January 4, 2021
Multicenter investigation of bowel evacuation function after transanal total mesorectal excision for mid-low rectal cancerZhanlong Shen, Gang Yu, Mingyang Ren, et al.
Annals of Surgery|July 11, 2022
Morbidity, Mortality, and Pathologic Outcomes of Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer Short-term Outcomes From a Multicenter Randomized Controlled TrialHuashan Liu, Ziwei Zeng, Hong Zhang, et al.
JAMA|January 23, 2025
Transanal vs Laparoscopic Total Mesorectal Excision and 3-Year Disease-Free Survival in Rectal Cancer: The TaLaR Randomized Clinical TrialZiwei Zeng, Shuangling Luo, Hong Zhang, et al.
Science Bulletin|December 22, 2022
Short-term and oncological outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer in China: a national database study of 5055 patientsXu Guan, Xiyue Hu, Zheng Jiang, et al.
The Lancet. Gastroenterology & Hepatology|March 26, 2026
Transanal total mesorectal excision versus laparoscopic total mesorectal excision for mid and low rectal cancer (COLOR III): short-term outcomes of an international, multicentre, phase 3, randomised, controlled, non-inferiority trialJurriaan B Tuynman, Hongwei Yao, Laura R Moolenaar, et al.
Pageof 4